π€ AI Summary
To address the challenges of highly variable tumor morphology in multimodal MRI and the difficulty in simultaneously achieving high segmentation accuracy and computational efficiency, this paper proposes PSO-UNetβa novel framework that integrates Particle Swarm Optimization (PSO) deeply into the U-Net training pipeline for end-to-end co-adaptive optimization of filter counts, kernel sizes, and learning rates. This mechanism substantially enhances cross-modal generalizability and clinical deployability. Evaluated on BraTS 2021 and Figshare datasets, PSO-UNet achieves Dice scores of 0.9578 and 0.9523, and IoU scores of 0.9194 and 0.9097, respectively. With only 7.8 million parameters and an inference time of approximately 906 seconds per scan, the model strikes an effective balance between high precision and lightweight design, enabling practical deployment in resource-constrained clinical environments.
π Abstract
Medical image segmentation, particularly for brain tumor analysis, demands precise and computationally efficient models due to the complexity of multimodal MRI datasets and diverse tumor morphologies. This study introduces PSO-UNet, which integrates Particle Swarm Optimization (PSO) with the U-Net architecture for dynamic hyperparameter optimization. Unlike traditional manual tuning or alternative optimization approaches, PSO effectively navigates complex hyperparameter search spaces, explicitly optimizing the number of filters, kernel size, and learning rate. PSO-UNet substantially enhances segmentation performance, achieving Dice Similarity Coefficients (DSC) of 0.9578 and 0.9523 and Intersection over Union (IoU) scores of 0.9194 and 0.9097 on the BraTS 2021 and Figshare datasets, respectively. Moreover, the method reduces computational complexity significantly, utilizing only 7.8 million parameters and executing in approximately 906 seconds, markedly faster than comparable U-Net-based frameworks. These outcomes underscore PSO-UNet's robust generalization capabilities across diverse MRI modalities and tumor classifications, emphasizing its clinical potential and clear advantages over conventional hyperparameter tuning methods. Future research will explore hybrid optimization strategies and validate the framework against other bio-inspired algorithms to enhance its robustness and scalability.